English | Español

Regulatory
+ Regulatory
Amanda Rupp | Oct 2, 2016

FDA approves GlaxoSmithKline treatment for rheumatoid arthritis
+ Regulatory
Amanda Rupp | Oct 2, 2016

Senate accelerates rare disease treatments for 15 million children
+ Regulatory
Amanda Rupp | Oct 2, 2016

Lawmakers achieve progress with 21st Century Cures legislation
+ Technology/Innovation
Amanda Rupp | Oct 2, 2016

Tina’s Wish raises millions for ovarian cancer research
+ Technology/Innovation
Amanda Rupp | Oct 1, 2016

NORD acquires federal funding to fight Zika
+ Community
Amanda Rupp | Oct 1, 2016

Amgen supports Blood Cancer Awareness Month
+ Community
Amanda Rupp | Oct 1, 2016

AHA emphasizes importance of patient-provider relationships
+ Regulatory
Amanda Rupp | Oct 1, 2016

NCI partners with Multiple Myeloma Research Foundation to build database

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation